Jae-hyeog Choi
Daegu, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Anti-HER2/Neu Antibody Therapy Inhibits HER2+ Breast Cancer by Blocking Myeloid-Derived Suppressor Cell Activity.
Journal: Oncology research and treatment
Published: June 11, 2025
HDAC4/5 Inhibitor, LMK-235 Improves Animal Voluntary Movement in MPTP-Induced Parkinson's Disease Model.
Journal: Pharmacology research & perspectives
Published: October 31, 2024
Dopaminergic cell protection and alleviation of neuropsychiatric disease symptoms by VMAT2 expression through the class I HDAC inhibitor TC-H 106.
Journal: Pharmacology research & perspectives
Published: July 06, 2023
Impact of Obesity on the IL-6 Immune Marker and Th17 Immune Cells in C57BL/6 Mice Models with Imiquimod-Induced Psoriasis.
Journal: International journal of molecular sciences
Published: February 18, 2023
ANO1-downregulation induced by schisandrathera D: a novel therapeutic target for the treatment of prostate and oral cancers.
Journal: Frontiers in pharmacology
Published: February 11, 2023
Combined treatment with anti-HER2/neu and anti-4-1BB monoclonal antibodies induces a synergistic antitumor effect but requires dose optimization to maintain immune memory for protection from lethal rechallenge.
Journal: Cancer immunology, immunotherapy : CII
Published: May 07, 2021
Addition of anti-neu antibody to local irradiation can improve tumor-bearing BALB/c mouse survival through immune-mediated mechanisms.
Journal: Radiation research
Published: February 24, 2015
A8, an anti-uPA agonistic antibody, promotes metastasis of cancer cells via ERK pathway.
Journal: Monoclonal antibodies in immunodiagnosis and immunotherapy
Published: October 31, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026